Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis
早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用
基本信息
- 批准号:10689664
- 负责人:
- 金额:$ 25.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-24 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAnimal ModelAntigensAreaArizonaAwardBudgetsBusinessesClinicalCoccidioidomycosisCollaborationsCommunicationCommunitiesDataDevelopmentDiagnosticEnsureEvaluationFacultyFamiliarityFeedbackFosteringFundingGoalsHuman ResourcesImmune responseIndividualInstitutionJointsKnowledgeLeadLeadershipLengthLifeLocationMedical centerMentorsMonitorNational Institute of Allergy and Infectious DiseaseOffice of Administrative ManagementPerformancePilot ProjectsPostdoctoral FellowPrimatesProductivityPublicationsReportingResearchResearch InstituteResearch Project GrantsResourcesRoleScheduleSchemeSeriesServicesStructureStudentsTimeTrainingTravelUnited States National Institutes of HealthUniversitiesVaccinesVideo RecordingVideoconferencingVirulenceWashingtonWorkclinical trial readinesscollaborative environmentdesert feverearly-career facultyexperiencein vivoinnovationmeetingsmembernovel vaccinesoutreachprogramsresearch and developmentstudent mentoringsuccesssynergismtimelinetranslational genomicsvirtualworking group
项目摘要
Administrative Core Section
SUMMARY
The Virulence, Immune Response, and Vaccine (VIRV) Cocci Cooperative Research Center (CCRC) will be
directed by the administrative core (AdC) and a senior management team (SMT). The SMT is composed of
Drs. Paul Keim (overall PI/PD), Bridget Barker, Deborah Fuller, and Erik Settles – all experienced scientific
project managers. This is an aggregate effort by Northern Arizona University, University of Washington, the
University of Arizona, the Kern Medical Center, the Tulane National Primate Research Center, and the
Translational Genomics Research Institute that will capitalize upon the strengths of each institution and will
synergistically foster a collaborative and productive scientific culture. Because it is a multi-Institutional
program, coordination and communication are essential and will be an emphasis in the AdC. All of the
individual Cores and Research Projects (RPs) will be represented on the SMT, which will provide effective
vertical and horizontal communication, and management. Weekly meetings will be held within each of the
CCRC components in addition to regular monthly cross-CCRC sessions to foster engagement and
collaboration across the projects. All meetings will be supported by video conferencing and recorded, to
lower participation barriers across the physical research locations. Slack accounts and channels will be an
important part of the management communication scheme. Financial and compliance monitoring, along with
reporting activities of the Cores and RPs, will be managed by the AdC, which includes a project manager
with business accounting support. Major services, such as publication, animal models, and travel will be
funded through the Cores to support the three individual RPs. Milestones and Timelines will be generated
for each component and reviewed monthly during the SMT meetings. Outreach activities will be assessed
and are part of the success metrics. Integral to these CCRC coordination efforts will be our program in
Development Research Projects (DRPs) that will foster early career faculty, cross CCRC participation, and
innovative ideas. The AdC will solicit, evaluate, award, and monitor the DRPs throughout the life of the
VIRV-CCRC. Outreach will include our virtual seminar program and online forums to support the Valley
Fever clinical and research communities, particular to other NIAID CCRC’s. Professional development,
training, and mentoring of students, postdoctoral fellows, and junior faculty will be encouraged and
supported by the AdC. Scientific working groups within and across the NIAID Cocci Centers will be fostered
with the seminar series, travel funds, and joint pilot projects. The VIRV-CCRC team members will be
expected to collaborate extensively and to produce relevant and impactful scientific products, including
potentially a novel vaccine ready for clinical trials.
行政核心组
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul Stephen Keim其他文献
Paul Stephen Keim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul Stephen Keim', 18)}}的其他基金
Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis
早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用
- 批准号:
10689662 - 财政年份:2022
- 资助金额:
$ 25.84万 - 项目类别:
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis
早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用
- 批准号:
10356626 - 财政年份:2022
- 资助金额:
$ 25.84万 - 项目类别:
Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis
早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用
- 批准号:
10356625 - 财政年份:2022
- 资助金额:
$ 25.84万 - 项目类别:
Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis
早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用
- 批准号:
10891793 - 财政年份:2022
- 资助金额:
$ 25.84万 - 项目类别:
Functional genomic analyses of emerging Cryptococcus subtypes in North America
北美新兴隐球菌亚型的功能基因组分析
- 批准号:
8386240 - 财政年份:2012
- 资助金额:
$ 25.84万 - 项目类别:
Functional genomic analyses of emerging Cryptococcus subtypes in North America
北美新兴隐球菌亚型的功能基因组分析
- 批准号:
8505370 - 财政年份:2012
- 资助金额:
$ 25.84万 - 项目类别:
Genomic Correlates with Differential Virulence in Melioidosis Animal Models
类鼻疽动物模型中基因组与差异毒力的相关性
- 批准号:
8260261 - 财政年份:2011
- 资助金额:
$ 25.84万 - 项目类别:
Molecular Antibiotic Resistance Arrays for clinical microbiology laboratories
用于临床微生物学实验室的分子抗生素耐药性芯片
- 批准号:
8281561 - 财政年份:2010
- 资助金额:
$ 25.84万 - 项目类别:
Molecular Antibiotic Resistance Arrays for clinical microbiology laboratories
用于临床微生物学实验室的分子抗生素耐药性芯片
- 批准号:
8477122 - 财政年份:2010
- 资助金额:
$ 25.84万 - 项目类别:
Molecular Antibiotic Resistance Arrays for clinical microbiology laboratories
用于临床微生物学实验室的分子抗生素耐药性芯片
- 批准号:
8088115 - 财政年份:2010
- 资助金额:
$ 25.84万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 25.84万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 25.84万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 25.84万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 25.84万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 25.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 25.84万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 25.84万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 25.84万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 25.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 25.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists